Form Type: 8-K Current Report filed by LabCorp Holdings Inc. on September 10, 2026 Item 7.01 - Regulation FD Disclosure: The filing indicates disclosure of information under Regulation Fair Disclosure Item 9.01 - Financial Statements and Exhibits: The filing includes financial statements and/or exhibits (document indicates 102 public documents included) Company Information: LabCorp Holdings Inc.,…

Our analysis rates this filing BULLISH. Labcorp's 2026 Investor Day filing presents a materially positive picture with minimal concerns. The company has reaffirmed near-term guidance while providing ambitious long-term targets through 2029, signaling management confidence in sustainable growth. The…

Concern level: LOW (1.8/10). Key factors: Risk score of 2.1 indicates minimal identified risks; No new risks identified in this filing period; No severity changes or risk escalations reported.

Notable risk changes: Investor Day disclosure of long-term financial guidance through 2029 with compound annual revenue growth of 5-8% and adjusted EPS growth of 8.5-11.5%; Reaffirmation of full-year 2026 guidance with revenue range of $14,710-$14,827 million (5.4-6.3% growth); Strategic priorities outlined focusing on specialty testing, pharma partnerships, personalized health solutions, and AI/robotics technology…